Introduction
Platelet activating factor (PAF, acetyl glyceryl ether phosphorylcholine) has been shown to produce strong and long-lasting hypotension in various animal species, e.g. normotensive and spontaneously hypertensive rats, rabbits, guinea-pigs, and dogs (Tanaka et al., 1983) . This action of PAF is thought to be endothelium-dependent (Kamitani et al., 1984; Kasuya et al., 1984a,b; Shigenobu et al., 1985; . In a previous study (Shigenobu et al., 1987) , we found that relatively low concentrations of PAF (10-9-10-7M) produced endothelium-dependent relaxation of the rat aorta in the presence of bovine serum albumin. This vasodilator action of PAF at low concentrations might be the cause of its hypotensive action in vivo. While the aorta will offer a resistance to flow, it is obvious that the contribution of vessels of smaller diameter to peripheral vascular resistance is much greater. In this regard, the mesenteric circulation of the rat receives approximately one-fifth of the cardiac output (Nichols et al., 1985) and, thus, regulation of this bed may make a significant contribution towards systemic blood pressure and circulating blood volume. In the present study, 1 Author for correspondence. therefore, we examined the effect of PAF on the resistance vessels of the rat mesenteric vascular bed and found that extremely low concentrations (10) (11) to 3 x 10-10M) can produce endothelium-dependent vasodilatation.
Methods

Perfusion of the mesenteric arterial bed
Male Wistar rats (190-360g) were killed by decapitation. The mesenteric arterial bed was removed and perfused according to the method described by McGregor (1965) , with various modifications. Briefly, the abdominal cavity was opened by midline incision, and the entire mesenteric arterial bed and associated intestinal tract was removed from the rat. The mesenteric artery and vein were tied off close to the caecum, and the remaining intestine was separated from the vascular bed along the intestinal wall. A cannula of PE90 tubing was inserted approximately 1.5cm into the superior mesenteric artery from its junction with the aorta and tied firmly. (Nihon Kohden, Model AP-2001 ) and recorded on a pen recorder (Yokogawa, Model 3021). After an equilibration period of 60min, the perfusion circuit was changed to a closed system, i.e., the perfusion solution was collected in a second bath and recirculated into the mesenteric arterial bed. The total volume of the closed system was 50ml, and agents were administered via the second bath. The mesenteric arterial bed was precontracted with 10-5M methoxamine. Acetylcholine (ACh) was administered cumulatively, but PAF was infused in single doses to avoid tachyphylaxis.
Removal of endothelium by detergents
The endothelium was removed by intraluminal perfusion with Krebs-Henseleit solution containing detergents (0.1% Triton X-100 for 30s or 0.3% CHAPS for 90s). After a re-equilibration period of 30 min, responses to ACh or PAF were examined.
Statistics
Since ACh was administered cumulatively and PAF was infused in single doses, EC50 data for ACh are presented as the mean + s.e.mean and EC50 data for PAF and CV-6209 are presented as 95% confidence limits (CL) of EC50 according to the method of Litchfield & Wilcoxon (1949) . Significance of differences was determined with Student's non-paired t test. 
Results
Perfused mesenteric arterial bed ofrat
The basal perfusion pressure of the rat mesenteric arterial bed was 51.4 + 1.2 mmHg (n = 10). Perfusion with methoxamine (10-5M) increased the perfusion pressure to 118.4 + 6.1 mmHg (n = 10).
Relaxation in response to ACh
In the perfused mesenteric arterial bed preconstricted with methoxamine (10-s M), infusion of increasing CV-6209 was 1.0 x 10-10M (95% CL = 3.1 x 10-1o2.8 x 10 9M, n = 5). CV-6209 (3 x 10 9M) had no effect on ACh-induced relaxation (data not shown). Infusion of lysoPAF (3 x 1010M) had no effect on the perfusion pressure of the mesentery (data not shown).
Effects ofdetergents on responses to ACh
Perfusion of the mesentery with detergents (0.1% Triton X-100, n = 5; 0.3% CHAPS, n = 3) produced a slight but significant increase in methoxamine (10-5M)-induced vasoconstriction (data not shown). Both detergents significantly suppressed the vasorelaxant response to ACh (1-0-1O-iM) (Figure 2 ). Pretreatment with indomethacin (10-6M) did not affect ACh-induced relaxation (data not shown).
Effects ofdetergents on responses to PAF PAF (3 x 10-10M)-induced vasodilatation was significantly inhibited by pretreatment of mesentery with Triton X-100 (0.1%, n = 5) or CHAPS (0.3%, n = 3). In contrast, pretreatment with indomethacin (10-6M) had no effect on PAF-induced vasodilatation ( Figure 3 ).
Discussion
Since Furchgott & Zawadzki (1980) demonstrated the obligatory role of endothelium in vascular relaxation by ACh, many studies have suggested that endothelium-derived relaxing factor (EDRF) is released from endothelial cells in response to a large number of agonists (Furchgott, 1984) . In the present study with perfused resistance vessels, ACh produced vasodilatation in a concentration-dependent manner and the vasorelaxant responses were significantly suppressed by perfusion with detergents such as CHAPS or Triton X-100. Since the detergents are Triton X-100). These data strongly suggest the possible involvement of the endothelium in the relaxation induced by PAF. CV-6209, a PAF antagonist, inhibited PAFinduced but not ACh-induced vasodilatation in a concentration-dependent manner. Specific antagonism by CV-6209 has already been obtained with respect to PAF-induced hypotension or platelet aggregation (Terashita et al., 1987 ). An accumulating body of evidence suggests that hypotension resulting from endotoxin challenge is due to the endogenous release of PAF from endothelial cells (Camussi et al., 1983) , leukocytes (Demopoules et al., 1979) , macrophages (Mencia-Huerta & Benveniste, 1979; Camussi et al., 1983) and platelets (Chingard et al., 1979) . Indeed, PAF antagonists can reverse established endotoxin-induced hypotension (Terashita et al., 1985; Handley et al., 1985a,b) . From the above data and the results of the present study, one possible explanation for endotoxin-induced hypotension may be that the release of PAF occurs, which then binds to its receptors located on the endothelial cells, stimulating production of EDRF.
Prostaglandin 12 a powerful vasodilator is synthesized by the endothelial cells (Moncada et al., 1977) .
However, Furchgott's group showed that AChinduced, endothelium-mediated vasodilatation was not modified by the cyclo-oxygenase inhibitor, indomethacin. We found that the endothelium-dependent vasodilatation induced by PAF was not inhibited by indomethacin, ruling out the involvement of vasodilator prostanoids. Furthermore, PAF at a low concentration showed neither chronotropic nor inotropic effects on the guinea-pig isolated right and left atria, respectively (Tanaka et al., 1983; Shigenobu et al., 1989) , excluding the possible involvement of cardiac depression in the PAF-induced hypotension.
In conclusion, we demonstrated that extremely low concentrations of PAF produce long-lasting vasodilatation in a resistance vessel of the mesenteric vasculature. Moreover, we showed that this PAFinduced vasodilatation is mediated by a vasodilator substance released from endothelial cells (EDRF) which is not a prostaglandin. Since the PAF-induced endothelium-dependent relaxation observed in the present study was elicited at low concentrations and was long-lasting, it may be the main mechanism by which PAF induces hypotension in vivo.
